
Cefimak OF 200mg/200mg Tablet
Marketer
Maksun Biotech Pvt Ltd
Salt Composition
Cefixime (200mg) + Ofloxacin (200mg)
Overview Cefimak OF 200mg/200mg Tablet
Bactrim-Duo 200mg/200mg tablets combat diverse bacterial infections through a synergistic drug combination. This prescription medication inhibits microbial proliferation, preventing infection spread. Adhere strictly to your physician's prescribed dosage and schedule; it may be taken with or without food. Exceeding the recommended dose can be harmful. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement; premature cessation may compromise effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are crucial for optimal recovery. Your doctor may order laboratory tests to monitor the medication's effects.
Uses of Cefimak OF 200mg/200mg Tablet
Combating Bacterial Infections
Major Benefits of Cefimak OF 200mg/200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Cefimak OF 200mg/200mg tablet whole; do not chew, crush, or divide it. While this medication can be taken with or without food, consistent timing is recommended.
How to use Cefimak OF 200mg/200mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cefimak OF 200mg/200mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Cefimak OF 200mg/200mg Tablet works:
Cefixime and Ofloxacin, combined as Cefimak OF 200mg/200mg tablets, offer a dual antibiotic approach to infection. Cefixime inhibits bacterial cell wall synthesis, disrupting a vital protective layer. Simultaneously, Ofloxacin interferes with bacterial DNA replication and repair mechanisms. This synergistic action ensures comprehensive infection control.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Cefimak OF 200mg/200mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Cefimak OF 200mg/200mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Cefimak OF 200mg/200mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Cefimak OF 200mg/200mg Tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Cefimak OF 200mg/200mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Cefimak OF 200mg/200mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Cefimak OF 200mg/200mg Tablet :
Should you forget a Cefimak OF 200mg/200mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cefimak OF 200mg/200mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
